Immune checkpoint inhibitors (ICPis) re-challenge : outcomes analysisin a french national cohortof non small cell lung cancer (NSCLC) patients.

E Gobbini , M Giaj Levra , M Pérol , C Chouaid , M Duruisseaux , J Bennouna , R Gervais , V Westeel , J Mazieres , F Guisier (1) , R Veillon , G Zalcman , E Giroux , Fr Vanel , M Wislez , E Dansin , R Descourt , C Decroisette , F Barlesi , N Girard , P Fournel , D Planchard , Y Oulkhouir , J Cadranel , B Duchemann , O Monier , A Toffart , D Moro-Sibilot

1 QuantIF-LITIS - Equipe Quantification en Imagerie Fonctionnelle

Domaines: Sciences du Vivant [q-bio]

E Gobbini, M Giaj Levra, M Pérol, C Chouaid, M Duruisseaux, et al.. Immune checkpoint inhibitors (ICPis) re-challenge : outcomes analysisin a french national cohortof non small cell lung cancer (NSCLC) patients.. World Conference on Lung Cancer, Sep 2019, Barcelone, Spain. ⟨hal-02626447⟩